ProfileGDS4132 / 236271_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 46% 46% 33% 33% 41% 40% 36% 39% 40% 37% 39% 38% 41% 42% 32% 40% 43% 41% 43% 42% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101121.72946
GSM201543Muscle PCOS pioglitazone 121114.04946
GSM201544Muscle PCOS pioglitazone 16186.193533
GSM201545Muscle PCOS pioglitazone 20190.494133
GSM201829Muscle PCOS pioglitazone 231114.13941
GSM201830Muscle PCOS pioglitazon 251106.35440
GSM201831Muscle PCOS pioglitazone 27191.358436
GSM201832Muscle PCOS pioglitazone 31100.45639
GSM201833Muscle PCOS pioglitazone 4196.139140
GSM201834Muscle PCOS pioglitazone 8192.673137
GSM201835Muscle PCOS after pioglitazone 10285.490139
GSM201836Muscle PCOS after pioglitazone 12287.918538
GSM201837Muscle PCOS after pioglitazone 16291.462841
GSM201838Muscle PCOS after pioglitazone 20298.685642
GSM201839Muscle PCOS after pioglitazone 23271.690732
GSM201840Muscle PCOS after pioglitazone 25299.783540
GSM201841Muscle PCOS after pioglitazone 27295.505543
GSM201842Muscle PCOS after pioglitazone 3286.286241
GSM201843Muscle PCOS after pioglitazone 42107.51443
GSM201844Muscle PCOS after pioglitazone 82105.50642